STOCK TITAN

Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Enovis (NYSE: ENOV) management will present at the Annual Jefferies Global Healthcare Conference in London on November 17, 2026.

The presentation is scheduled for 11:30 a.m. GMT (6:30 a.m. ET). A live audio webcast and replay will be available on the company’s website under Investors, Events and Presentations.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 11:30 a.m. GMT (6:30 a.m. ET).

A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.

About Enovis 

Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.  

Investor Contact

Kyle Rose, Vice President, Investor Relations
investorrelations@enovis.com

Media Contact

Rachel Colloff, Sr. Director, Corporate Communications
Rachel.Colloff@enovis.com


Keep reading